Chinar Therapeutics Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 16-11-2024
- Paid Up Capital ₹ 0.10 M
as on 16-11-2024
- Company Age 7 Year, 6 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1.24 Cr
as on 16-11-2024
- Revenue 2.90%
(FY 2023)
- Profit 5.27%
(FY 2023)
- Ebitda 14.74%
(FY 2023)
- Net Worth 35.23%
(FY 2023)
- Total Assets 32.36%
(FY 2023)
About Chinar Therapeutics
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹1.24 Cr.
Swati Sharma and Naresh Sharma serve as directors at the Company.
- CIN/LLPIN
U74999RJ2017PTC058432
- Company No.
058432
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
28 Jun 2017
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Jaipur
Industry
Company Details
- Location
Udaipur, Rajasthan, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Chinar Therapeutics?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Swati Sharma  | Director | 28-Jun-2017 | Current |
| Naresh Sharma | Director | 28-Jun-2017 | Current |
Financial Performance of Chinar Therapeutics.
Chinar Therapeutics Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 2.9% increase. The company also saw a slight improvement in profitability, with a 5.27% increase in profit. The company's net worth Soared by an impressive increase of 35.23%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Chinar Therapeutics?
In 2023, Chinar Therapeutics had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 31 Mar 2024 | ₹4.95 M | Open |
Others Creation Date: 31 Mar 2024 | ₹1.65 M | Open |
Yes Bank Limited Creation Date: 07 Dec 2022 | ₹5.00 M | Open |
How Many Employees Work at Chinar Therapeutics?
Chinar Therapeutics has a workforce of 32 employees as of Apr 04, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Chinar Therapeutics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Chinar Therapeutics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
